Literature DB >> 27917772

Awareness, perceived risk and practices related to cervical cancer and Pap smear screening: A cross-sectional study among HIV-positive women attending an urban HIV clinic in Johannesburg, South Africa.

Idah Mokhele1, D Evans, K Schnippel, A Swarts, J S Smith, C Firnhaber.   

Abstract

BACKGROUND: Cervical cancer is a major cause of cancer-related deaths, especially in the context of the HIV epidemic.
OBJECTIVE: To examine awareness, perceived risk and practices related to cervical cancer screening among HIV-positive women.
METHODS: Interviewer-administered structured questionnaires were administered to HIV-positive women (aged ≥18 years) enrolled in a cervical cancer screening study at the Themba Lethu Clinic, Johannesburg, South Africa, from November 2009 to December 2011. Modified Poisson regression with robust standard errors was used to identify factors at enrolment associated with awareness, perceived risk and adequate practice related to cervical screening. Adjusted relative risks (aRRs) with 95% confidence intervals (CIs) are presented.
RESULTS: Of the 1 202 women enrolled, 71.3% and 18.2% were aware of the Pap smear and HPV, respectively. Of the 1 192 participants with data evaluated, 76.5% were worried and 23.5% were not worried about cervical cancer; 28.6% of the women had adequate screening practice. Older age (40 - 49 years or ≥50 years v. 18 - 29 years) (aRR 1.63, 95% CI 1.12 - 2.37; aRR 2.22, 95% CI 1.44 - 3.41), higher education (tertiary v. less than grade 10) (aRR 1.39, 95% CI 1.00 - 1.93), initiation on combination antiretroviral therapy (aRR 1.36, 95% CI 1.00 - 1.85) and awareness of Pap smear screening (aRR 16.18, 95% CI 7.69 - 34.01) were associated with adequate screening practice.
CONCLUSIONS: High levels of Pap smear awareness and low levels of Pap smear screening uptake were observed. However, Pap smear awareness was associated with adequate screening practice. More research into effective health education programmes to address these gaps is needed.

Entities:  

Year:  2016        PMID: 27917772     DOI: 10.7196/SAMJ.2016.v106.i12.11224

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Knowledge and Practices of Cervical Cancer and Its Prevention Among Malawian Women.

Authors:  Johanna E Maree; Mary Kampinda-Banda
Journal:  J Cancer Educ       Date:  2020-02       Impact factor: 2.037

2.  Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.

Authors:  Abiyu Ayalew Assefa; Feleke Hailemichael Astawesegn; Bethlehem Eshetu
Journal:  BMC Health Serv Res       Date:  2019-11-19       Impact factor: 2.655

3.  Factors associated with cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania: A cross-sectional study.

Authors:  Meshack R Mwantake; Happiness D Kajoka; Faustini C Kimondo; Caroline Amour; Innocent B Mboya
Journal:  Prev Med Rep       Date:  2022-09-19

4.  Choropleth Mapping of Cervical Cancer Screening in South Africa Using Healthcare Facility-level Data from the National Laboratory Network.

Authors:  Caroline B T Makura; Kathryn Schnippel; Pamela Michelow; Carla J Chibwesha; Bridgette Goeieman; Suzette Jordaan; Cynthia Firnhaber
Journal:  AIMS Public Health       Date:  2016-10-19

5.  Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign.

Authors:  Sinead Delany-Moretlwe; Karen F Kelley; Shamagonam James; Fiona Scorgie; Hasina Subedar; Nonhlanhla R Dlamini; Yogan Pillay; Nicolette Naidoo; Admire Chikandiwa; Helen Rees
Journal:  Glob Health Sci Pract       Date:  2018-10-04

6.  Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.

Authors:  Faustini C Kimondo; Happiness D Kajoka; Meshack R Mwantake; Caroline Amour; Innocent B Mboya
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.